• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Broad Institute - Articles and news items


Broad Institute Genomic Services offers genomic insight into Ninlaro

Industry news / 25 January 2016 / Victoria White

Ninlaro (ixazomib) was recently approved by the FDA, indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma…


Win an Amazon Gift Card worth up to €100!TAKE OUR SURVEY
+ +